HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
최신 재무제표(Form-10K)에 따르면, Heartbeam Inc의 총 자산은 $0이며, 순손실입니다.
BEAT의 주요 재무 비율은 무엇인가요?
Heartbeam Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Heartbeam Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Heartbeam Inc 주요 수익원은 Refining and Petrochemicals이며, 최신 수익 발표에서 수익은 58,846,000,000,000입니다. 지역별로는 Colombia이 Heartbeam Inc의 주요 시장이며, 수익은 58,038,000,000,000입니다.